Company or ticker...

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for non-alcoholic steatohepatitis (NASH) and other liver diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

MDGL

10.1B

7.9

n/a

-24.79%

Key Facts

M. Cap

PS

PE

YTD

10.1B

7.9

n/a

-24.79%

10MA

20MA

50MA

200MA

$MDGL